For the Inventor, By the Inventor

Enter assignee name

Hsc Research and Development Limited Partnership

USPTO Granted Patents = 36

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 394

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Johanna Rommens (10 out of 39 patents)

Peter H St George-Hyslop (7 out of 23 patents)

Paul E Fraser (7 out of 25 patents)

4. Clifford A Lingwood (4 out of 18 patents)

5. Lap-Chee Tsui (3 out of 11 patents)

6. Joan Massague (2 out of 20 patents)

7. Don J Mahuran (2 out of 14 patents)

8. Richard C Hill (2 out of 6 patents)

9. Chaim M Roifman (2 out of 8 patents)

10. Thomas Grunberger (2 out of 5 patents)

11. Ruth Geva, Legal Representative (2 out of 2 patents)

12. Leorah Kroyanker, Legal Representative (2 out of 2 patents)

13. Olga Rounova (2 out of 7 patents)

14. Nigel Sharfe (2 out of 4 patents)

15. Garth L Fletcher (2 out of 3 patents)

36 patents: Sort by Forward Citations

1. 8058243 - Method for treating a brain cancer with ifenprodil (2011-11-15),

2. 7846679 - Methods for detecting the presence of mutant mammalian presenilin protein (2010-12-07),

3. 7838247 - Antibody specific for mutant presenilin 2 and method of use thereof (2010-11-23),

4. 7598419 - Compounds for modulating cell proliferation (2009-10-06),

5. 7560426 - Verotoxin pharmaceutical compositions and medical treatments therewith (2009-07-14),

6. 7507798 - Antibody specific for mutant presenilin 1 (2009-03-24),

7. 7208468 - Verotoxin pharmaceutical compositions and medical treatments therewith (2007-04-24),

8. 7118886 - Ese genes and proteins (2006-10-10),

9. 7105636 - SARA proteins (2006-09-12),

10. 6998467 - Antibody specific for presenilin 1 and method of use thereof (2006-02-14),

11. 6800659 - Compounds for modulating cell proliferation (2004-10-05),

12. 6696272 - Products and methods for gaucher disease therapy (2004-02-24),

13. 6524851 - Hybrid nucleic acid molecules and vectors including &bgr;-globin regulatory elements (2003-02-25),

14. 6429293 - Sculpin-type antifreeze polypeptides and nucleic acids (2002-08-06),

15. 6423680 - Inhibitor of platelet activating factor (2002-07-23),

HSC Research and Development Limited Partnership is a leading research and development company specializing in innovative solutions for various industries. With a team of highly skilled professionals and state-of-the-art facilities, we strive to push the boundaries of technology and drive advancements in science. Our areas of expertise include biotechnology, pharmaceuticals, engineering, and environmental sciences. Visit our website to learn more about our projects, collaborations, and contributions to the global research community.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#42 in

#354 in Canada

#18,179 in the World

Hsc Research and Development Limited Partnership

Forward Citations = 394

71 inventors:

Johanna Rommens (10 out of 39 patents)

Peter H St George-Hyslop (7 out of 23 patents)

Paul E Fraser (7 out of 25 patents)

4. Clifford A Lingwood (4 out of 18 patents)

5. Lap-Chee Tsui (3 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…